LayerRx Mapping ID
268
Slot System
Featured Buckets
Featured Buckets Admin

Sinusitis: Allergies, antibiotics, aspirin, asthma

Article Type
Changed
Tue, 08/14/2018 - 12:56
Display Headline
Sinusitis: Allergies, antibiotics, aspirin, asthma
Article PDF
Author and Disclosure Information

Cristine Radojicic, MD
Section of Allergy, Department of Pulmonary, Allergy, and Critical Care Medicine, Cleveland Clinic

Address: Christine Radojicic, MD, Department of Pulmonary, Allergy, and Critical Care Medicine, C22, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail [email protected]

Issue
Cleveland Clinic Journal of Medicine - 73(7)
Publications
Topics
Page Number
671-678
Sections
Author and Disclosure Information

Cristine Radojicic, MD
Section of Allergy, Department of Pulmonary, Allergy, and Critical Care Medicine, Cleveland Clinic

Address: Christine Radojicic, MD, Department of Pulmonary, Allergy, and Critical Care Medicine, C22, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail [email protected]

Author and Disclosure Information

Cristine Radojicic, MD
Section of Allergy, Department of Pulmonary, Allergy, and Critical Care Medicine, Cleveland Clinic

Address: Christine Radojicic, MD, Department of Pulmonary, Allergy, and Critical Care Medicine, C22, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail [email protected]

Article PDF
Article PDF
Issue
Cleveland Clinic Journal of Medicine - 73(7)
Issue
Cleveland Clinic Journal of Medicine - 73(7)
Page Number
671-678
Page Number
671-678
Publications
Publications
Topics
Article Type
Display Headline
Sinusitis: Allergies, antibiotics, aspirin, asthma
Display Headline
Sinusitis: Allergies, antibiotics, aspirin, asthma
Sections
PURLs Copyright

Disallow All Ads
Alternative CME
Use ProPublica
Article PDF Media

Drug adjuncts for treating alcohol dependence

Article Type
Changed
Tue, 08/14/2018 - 12:33
Display Headline
Drug adjuncts for treating alcohol dependence
Article PDF
Author and Disclosure Information

Gregory B. Collins, MD
Section head, Alcohol and Drug Recovery Center, Department of Psychiatry and Psychology, Cleveland Clinic

Mark S. McAllister, MD
Alcohol and Drug Recovery Center, Department of Psychiatry and Psychology, Cleveland Clinic

Kamala Adury, MD
Alcohol and Drug Recovery Center, Department of Psychiatry and Psychology, Cleveland Clinic

Address: Gregory B. Collins, MD, Alcohol and Drug Recovery Center, Department of Psychiatry and Psychology, P48, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail [email protected]

Issue
Cleveland Clinic Journal of Medicine - 73(7)
Publications
Topics
Page Number
641-644, 647-648, 650-651, 656
Sections
Author and Disclosure Information

Gregory B. Collins, MD
Section head, Alcohol and Drug Recovery Center, Department of Psychiatry and Psychology, Cleveland Clinic

Mark S. McAllister, MD
Alcohol and Drug Recovery Center, Department of Psychiatry and Psychology, Cleveland Clinic

Kamala Adury, MD
Alcohol and Drug Recovery Center, Department of Psychiatry and Psychology, Cleveland Clinic

Address: Gregory B. Collins, MD, Alcohol and Drug Recovery Center, Department of Psychiatry and Psychology, P48, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail [email protected]

Author and Disclosure Information

Gregory B. Collins, MD
Section head, Alcohol and Drug Recovery Center, Department of Psychiatry and Psychology, Cleveland Clinic

Mark S. McAllister, MD
Alcohol and Drug Recovery Center, Department of Psychiatry and Psychology, Cleveland Clinic

Kamala Adury, MD
Alcohol and Drug Recovery Center, Department of Psychiatry and Psychology, Cleveland Clinic

Address: Gregory B. Collins, MD, Alcohol and Drug Recovery Center, Department of Psychiatry and Psychology, P48, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail [email protected]

Article PDF
Article PDF
Issue
Cleveland Clinic Journal of Medicine - 73(7)
Issue
Cleveland Clinic Journal of Medicine - 73(7)
Page Number
641-644, 647-648, 650-651, 656
Page Number
641-644, 647-648, 650-651, 656
Publications
Publications
Topics
Article Type
Display Headline
Drug adjuncts for treating alcohol dependence
Display Headline
Drug adjuncts for treating alcohol dependence
Sections
PURLs Copyright

Disallow All Ads
Alternative CME
Use ProPublica
Article PDF Media

We try to walk the line

Article Type
Changed
Tue, 08/14/2018 - 09:26
Display Headline
We try to walk the line
Article PDF
Author and Disclosure Information

Brian F. Mandell, MD, PhD
Editor in Chief

Issue
Cleveland Clinic Journal of Medicine - 73(6)
Publications
Topics
Page Number
504
Sections
Author and Disclosure Information

Brian F. Mandell, MD, PhD
Editor in Chief

Author and Disclosure Information

Brian F. Mandell, MD, PhD
Editor in Chief

Article PDF
Article PDF
Related Articles
Issue
Cleveland Clinic Journal of Medicine - 73(6)
Issue
Cleveland Clinic Journal of Medicine - 73(6)
Page Number
504
Page Number
504
Publications
Publications
Topics
Article Type
Display Headline
We try to walk the line
Display Headline
We try to walk the line
Sections
PURLs Copyright

Disallow All Ads
Alternative CME
Use ProPublica
Article PDF Media

Inhaled human insulin: An inspiration for patients with diabetes mellitus?

Article Type
Changed
Tue, 05/03/2022 - 16:09
Display Headline
Inhaled human insulin: An inspiration for patients with diabetes mellitus?
Article PDF
Author and Disclosure Information

Michael B. Davidson, DO
Department of Endocrinology, Diabetes, and Metabolism, Cleveland Clinic

Adi E. Mehta, MD
Department of Endocrinology, Diabetes, and Metabolism, Cleveland Clinic

Elias S. Siraj, MD
Department of Endocrinology, Diabetes, and Metabolism, Cleveland Clinic

Address: Elias S. Siraj, MD, Department of Endocrinology, Diabetes, and Metabolism, A53, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail [email protected]

Issue
Cleveland Clinic Journal of Medicine - 73(6)
Publications
Topics
Page Number
569-578
Sections
Author and Disclosure Information

Michael B. Davidson, DO
Department of Endocrinology, Diabetes, and Metabolism, Cleveland Clinic

Adi E. Mehta, MD
Department of Endocrinology, Diabetes, and Metabolism, Cleveland Clinic

Elias S. Siraj, MD
Department of Endocrinology, Diabetes, and Metabolism, Cleveland Clinic

Address: Elias S. Siraj, MD, Department of Endocrinology, Diabetes, and Metabolism, A53, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail [email protected]

Author and Disclosure Information

Michael B. Davidson, DO
Department of Endocrinology, Diabetes, and Metabolism, Cleveland Clinic

Adi E. Mehta, MD
Department of Endocrinology, Diabetes, and Metabolism, Cleveland Clinic

Elias S. Siraj, MD
Department of Endocrinology, Diabetes, and Metabolism, Cleveland Clinic

Address: Elias S. Siraj, MD, Department of Endocrinology, Diabetes, and Metabolism, A53, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail [email protected]

Article PDF
Article PDF
Related Articles
Issue
Cleveland Clinic Journal of Medicine - 73(6)
Issue
Cleveland Clinic Journal of Medicine - 73(6)
Page Number
569-578
Page Number
569-578
Publications
Publications
Topics
Article Type
Display Headline
Inhaled human insulin: An inspiration for patients with diabetes mellitus?
Display Headline
Inhaled human insulin: An inspiration for patients with diabetes mellitus?
Sections
PURLs Copyright

Disallow All Ads
Alternative CME
Use ProPublica
Article PDF Media

Inhaled human insulin: Coup or caution?

Article Type
Changed
Tue, 05/03/2022 - 16:09
Display Headline
Inhaled human insulin: Coup or caution?
Article PDF
Author and Disclosure Information

James K. Stoller, MD, MS
Professor of Medicine, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University; Executive Director of Leadership Development, Vice-Chairman, Division of Medicine, and Head, Section of Respiratory Therapy, Department of Pulmonary, Allergy, and Critical Care Medicine, Cleveland Clinic; member, US Food and Drug Administration Endocrinology and Metabolism Advisory Committee

Address: James K. Stoller, MD, MS, Department of Pulmonary, Allergy, and Critical Care Medicine, A90, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195

Issue
Cleveland Clinic Journal of Medicine - 73(6)
Publications
Topics
Page Number
580-582
Sections
Author and Disclosure Information

James K. Stoller, MD, MS
Professor of Medicine, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University; Executive Director of Leadership Development, Vice-Chairman, Division of Medicine, and Head, Section of Respiratory Therapy, Department of Pulmonary, Allergy, and Critical Care Medicine, Cleveland Clinic; member, US Food and Drug Administration Endocrinology and Metabolism Advisory Committee

Address: James K. Stoller, MD, MS, Department of Pulmonary, Allergy, and Critical Care Medicine, A90, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195

Author and Disclosure Information

James K. Stoller, MD, MS
Professor of Medicine, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University; Executive Director of Leadership Development, Vice-Chairman, Division of Medicine, and Head, Section of Respiratory Therapy, Department of Pulmonary, Allergy, and Critical Care Medicine, Cleveland Clinic; member, US Food and Drug Administration Endocrinology and Metabolism Advisory Committee

Address: James K. Stoller, MD, MS, Department of Pulmonary, Allergy, and Critical Care Medicine, A90, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195

Article PDF
Article PDF
Related Articles
Issue
Cleveland Clinic Journal of Medicine - 73(6)
Issue
Cleveland Clinic Journal of Medicine - 73(6)
Page Number
580-582
Page Number
580-582
Publications
Publications
Topics
Article Type
Display Headline
Inhaled human insulin: Coup or caution?
Display Headline
Inhaled human insulin: Coup or caution?
Sections
PURLs Copyright

Disallow All Ads
Alternative CME
Use ProPublica
Article PDF Media

Should beta-blockers be discontinued when a patient is admitted to the hospital with acutely decompensated heart failure?

Article Type
Changed
Tue, 08/14/2018 - 09:57
Display Headline
Should beta-blockers be discontinued when a patient is admitted to the hospital with acutely decompensated heart failure?
Article PDF
Author and Disclosure Information

Wassim H. Fares, MD
Department of General Internal Medicine, Cleveland Clinic

Ashish Aneja, MD
Department of General Internal Medicine, Cleveland Clinic

Address: Wassim H. Fares, MD, Department of General Internal Medicine, S70, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail [email protected]

Issue
Cleveland Clinic Journal of Medicine - 73(6)
Publications
Topics
Page Number
557-559
Sections
Author and Disclosure Information

Wassim H. Fares, MD
Department of General Internal Medicine, Cleveland Clinic

Ashish Aneja, MD
Department of General Internal Medicine, Cleveland Clinic

Address: Wassim H. Fares, MD, Department of General Internal Medicine, S70, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail [email protected]

Author and Disclosure Information

Wassim H. Fares, MD
Department of General Internal Medicine, Cleveland Clinic

Ashish Aneja, MD
Department of General Internal Medicine, Cleveland Clinic

Address: Wassim H. Fares, MD, Department of General Internal Medicine, S70, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail [email protected]

Article PDF
Article PDF
Issue
Cleveland Clinic Journal of Medicine - 73(6)
Issue
Cleveland Clinic Journal of Medicine - 73(6)
Page Number
557-559
Page Number
557-559
Publications
Publications
Topics
Article Type
Display Headline
Should beta-blockers be discontinued when a patient is admitted to the hospital with acutely decompensated heart failure?
Display Headline
Should beta-blockers be discontinued when a patient is admitted to the hospital with acutely decompensated heart failure?
Sections
PURLs Copyright

Disallow All Ads
Alternative CME
Use ProPublica
Article PDF Media

Addressing the challenges of cardiorenal syndrome

Article Type
Changed
Tue, 08/14/2018 - 09:06
Display Headline
Addressing the challenges of cardiorenal syndrome
Article PDF
Author and Disclosure Information

Carrie Geisberg, MD
Cardiology Division, Vanderbilt University, Nashville, TN

Javed Butler, MD, MPH
Director, Heart and Heart-Lung Transplant Program, Cardiology Division, Vanderbilt University, Nashville, TN

Address: Javed Butler, MD, MPH, Cardiology Division, 383-PRB, Vanderbilt University Medical Center, Nashville, TN 37232-6300; e-mail [email protected]

Issue
Cleveland Clinic Journal of Medicine - 73(5)
Publications
Topics
Page Number
485-491
Sections
Author and Disclosure Information

Carrie Geisberg, MD
Cardiology Division, Vanderbilt University, Nashville, TN

Javed Butler, MD, MPH
Director, Heart and Heart-Lung Transplant Program, Cardiology Division, Vanderbilt University, Nashville, TN

Address: Javed Butler, MD, MPH, Cardiology Division, 383-PRB, Vanderbilt University Medical Center, Nashville, TN 37232-6300; e-mail [email protected]

Author and Disclosure Information

Carrie Geisberg, MD
Cardiology Division, Vanderbilt University, Nashville, TN

Javed Butler, MD, MPH
Director, Heart and Heart-Lung Transplant Program, Cardiology Division, Vanderbilt University, Nashville, TN

Address: Javed Butler, MD, MPH, Cardiology Division, 383-PRB, Vanderbilt University Medical Center, Nashville, TN 37232-6300; e-mail [email protected]

Article PDF
Article PDF
Related Articles
Issue
Cleveland Clinic Journal of Medicine - 73(5)
Issue
Cleveland Clinic Journal of Medicine - 73(5)
Page Number
485-491
Page Number
485-491
Publications
Publications
Topics
Article Type
Display Headline
Addressing the challenges of cardiorenal syndrome
Display Headline
Addressing the challenges of cardiorenal syndrome
Sections
Disallow All Ads
Alternative CME
Use ProPublica
Article PDF Media

Exenatide and pramlintide: New glucose-lowering agents for treating diabetes mellitus

Article Type
Changed
Tue, 05/03/2022 - 16:09
Display Headline
Exenatide and pramlintide: New glucose-lowering agents for treating diabetes mellitus
Article PDF
Author and Disclosure Information

Byron J. Hoogwerf, MD
Department of Endocrinology, Diabetes, and Metabolism, Cleveland Clinic

Address: Byron J. Hoogwerf, MD, Department of Endocrinology, Diabetes, and Metabolism, A53, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail [email protected]

The author has indicated that he serves on an advisory committee to develop educational materials for the Amylin/Lilly Synergy partnership.

Issue
Cleveland Clinic Journal of Medicine - 73(5)
Publications
Topics
Page Number
477-484
Sections
Author and Disclosure Information

Byron J. Hoogwerf, MD
Department of Endocrinology, Diabetes, and Metabolism, Cleveland Clinic

Address: Byron J. Hoogwerf, MD, Department of Endocrinology, Diabetes, and Metabolism, A53, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail [email protected]

The author has indicated that he serves on an advisory committee to develop educational materials for the Amylin/Lilly Synergy partnership.

Author and Disclosure Information

Byron J. Hoogwerf, MD
Department of Endocrinology, Diabetes, and Metabolism, Cleveland Clinic

Address: Byron J. Hoogwerf, MD, Department of Endocrinology, Diabetes, and Metabolism, A53, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail [email protected]

The author has indicated that he serves on an advisory committee to develop educational materials for the Amylin/Lilly Synergy partnership.

Article PDF
Article PDF
Issue
Cleveland Clinic Journal of Medicine - 73(5)
Issue
Cleveland Clinic Journal of Medicine - 73(5)
Page Number
477-484
Page Number
477-484
Publications
Publications
Topics
Article Type
Display Headline
Exenatide and pramlintide: New glucose-lowering agents for treating diabetes mellitus
Display Headline
Exenatide and pramlintide: New glucose-lowering agents for treating diabetes mellitus
Sections
PURLs Copyright

Disallow All Ads
Alternative CME
Use ProPublica
Article PDF Media

Do thiazolidinediones cause heart failure? A critical review

Article Type
Changed
Tue, 05/03/2022 - 16:09
Display Headline
Do thiazolidinediones cause heart failure? A critical review
Article PDF
Author and Disclosure Information

W.H. Wilson Tang, MD
Section of Heart Failure and Cardiac Transplantation, Department of Cardiovascular Medicine, Cleveland Clinic

Address: W.H. Wilson Tang, MD, Department of Cardiovascular Medicine, F25, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail [email protected]

Dr. Tang has indicated that he previously served as a consultant for GlaxoSmithKline Pharmaceuticals, Amylin Pharmaceuticals, and F. Hoffmann-La Roche Ltd. He is a member of the speakers’ bureau for Takeda Pharmaceuticals.

Issue
Cleveland Clinic Journal of Medicine - 73(4)
Publications
Topics
Page Number
390-397
Sections
Author and Disclosure Information

W.H. Wilson Tang, MD
Section of Heart Failure and Cardiac Transplantation, Department of Cardiovascular Medicine, Cleveland Clinic

Address: W.H. Wilson Tang, MD, Department of Cardiovascular Medicine, F25, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail [email protected]

Dr. Tang has indicated that he previously served as a consultant for GlaxoSmithKline Pharmaceuticals, Amylin Pharmaceuticals, and F. Hoffmann-La Roche Ltd. He is a member of the speakers’ bureau for Takeda Pharmaceuticals.

Author and Disclosure Information

W.H. Wilson Tang, MD
Section of Heart Failure and Cardiac Transplantation, Department of Cardiovascular Medicine, Cleveland Clinic

Address: W.H. Wilson Tang, MD, Department of Cardiovascular Medicine, F25, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail [email protected]

Dr. Tang has indicated that he previously served as a consultant for GlaxoSmithKline Pharmaceuticals, Amylin Pharmaceuticals, and F. Hoffmann-La Roche Ltd. He is a member of the speakers’ bureau for Takeda Pharmaceuticals.

Article PDF
Article PDF
Related Articles
Issue
Cleveland Clinic Journal of Medicine - 73(4)
Issue
Cleveland Clinic Journal of Medicine - 73(4)
Page Number
390-397
Page Number
390-397
Publications
Publications
Topics
Article Type
Display Headline
Do thiazolidinediones cause heart failure? A critical review
Display Headline
Do thiazolidinediones cause heart failure? A critical review
Sections
PURLs Copyright

Disallow All Ads
Alternative CME
Use ProPublica
Article PDF Media

New therapies for type 2 diabetes based on glucagon-like peptide 1

Article Type
Changed
Tue, 05/03/2022 - 16:09
Display Headline
New therapies for type 2 diabetes based on glucagon-like peptide 1
Article PDF
Author and Disclosure Information

Marzieh Salehi, MD
Division of Endocrinology and Metabolism, University of Cincinnati Medical Center, Cincinnati, OH

David A. D’Alessio, MD
Division of Endocrinology and Metabolism, University of Cincinnati Medical Center, Cincinnati, OH

Address: Marzieh Salehi, MD, Division of Endocrinology and Metabolism, University of Cincinnati Medical Center, PO Box 670547, Cincinnati, OH 45267-0547; e-mail [email protected]

Issue
Cleveland Clinic Journal of Medicine - 73(4)
Publications
Topics
Page Number
382-389
Sections
Author and Disclosure Information

Marzieh Salehi, MD
Division of Endocrinology and Metabolism, University of Cincinnati Medical Center, Cincinnati, OH

David A. D’Alessio, MD
Division of Endocrinology and Metabolism, University of Cincinnati Medical Center, Cincinnati, OH

Address: Marzieh Salehi, MD, Division of Endocrinology and Metabolism, University of Cincinnati Medical Center, PO Box 670547, Cincinnati, OH 45267-0547; e-mail [email protected]

Author and Disclosure Information

Marzieh Salehi, MD
Division of Endocrinology and Metabolism, University of Cincinnati Medical Center, Cincinnati, OH

David A. D’Alessio, MD
Division of Endocrinology and Metabolism, University of Cincinnati Medical Center, Cincinnati, OH

Address: Marzieh Salehi, MD, Division of Endocrinology and Metabolism, University of Cincinnati Medical Center, PO Box 670547, Cincinnati, OH 45267-0547; e-mail [email protected]

Article PDF
Article PDF
Issue
Cleveland Clinic Journal of Medicine - 73(4)
Issue
Cleveland Clinic Journal of Medicine - 73(4)
Page Number
382-389
Page Number
382-389
Publications
Publications
Topics
Article Type
Display Headline
New therapies for type 2 diabetes based on glucagon-like peptide 1
Display Headline
New therapies for type 2 diabetes based on glucagon-like peptide 1
Sections
PURLs Copyright

Disallow All Ads
Alternative CME
Use ProPublica
Article PDF Media